Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.50 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.48 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.42 |
| ▸ | GNPAT | O15228 | 1/20 | 0.42 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.42 |
| ▸ | NOD1 | Q9Y239 | 3/20 | 0.41 |
| ▸ | C3AR1 | Q16581 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | ITGB3 | P05106 | 2/20 | 0.39 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.39 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.38 |
| ▸ | MMP2 | P08253 | 1/20 | 0.38 |
| ▸ | MMP9 | P14780 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12914891 | 0.95 | SLC6A5 (0.54) | SLC6A5FOLH1PTGS1PTGS2GNPAT | |
| SCHEMBL31722260 | 0.95 | SLC6A5 (0.54) | SLC6A5FOLH1PTGS1PTGS2GNPAT | |
| SCHEMBL21152612 | 0.95 | SLC6A5 (0.54) | SLC6A5FOLH1PTGS1PTGS2GNPAT | |
| SCHEMBL31722125 | 0.95 | SLC6A5 (0.54) | SLC6A5FOLH1PTGS1PTGS2GNPAT | |
| SCHEMBL29695436 | 0.95 | SLC6A5 (0.54) | SLC6A5FOLH1PTGS1PTGS2GNPAT | |
| SCHEMBL5501792 | 0.94 | FOLH1 (0.49) | SLC6A5FOLH1PTGS1PTGS2GNPAT | |
| SCHEMBL22388827 | 0.87 | NOD1 (0.57) | SLC6A5PTGS1PTGS2NOD1 | |
| SCHEMBL22044504 | 0.87 | PTGS1 (0.46) | PTGS1PTGS2GNPATC3AR1 | |
| SCHEMBL22389098 | 0.86 | ALB (0.47) | FOLH1PTGS1PTGS2NOD1 | |
| SCHEMBL23983021 | 0.85 | PTGS1 (0.45) | SLC6A5FOLH1PTGS1PTGS2GNPAT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1711108-A | Method for the selective and quantitative functionalization of immunoglobulin Fab fragments, conjugate compounds obtained with the same and compositions thereof | BRACCO IMAGING SPA (IT) | 2005-12-21 | — | — | CN | claimed |
| US-6274325-B1 | USING A FAB'-BIOTIN MATERIAL AND AGGLUTINATABLE PARTICLES WHICH CARRY STREPTAVIDIN OR AVIDIN | BOEHRINGER MANNHEIM GMBH (DE) | 2001-08-14 | — | — | US | claimed |
| EP-4642484-A1 | TARGETED TREATMENT OF PROSTATE CANCERS AND OTHER TUMORS BY AN ANTIBODY-DRUG CONJUGATE | Hangzhou Seehe Biotechnology Co., Ltd (CN) | 2025-11-05 | — | — | EP | disclosed |
| WO-2024239281-A1 | TARGETED TREATMENT OF PROSTATE CANCERS AND OTHER TUMORS BY AN ANTIBODY-DRUG CONJUGATE | HANGZHOU SEEHE BIOTECHNOLOGY CO., LTD (CN) | 2024-11-28 | — | — | WO | disclosed |
| US-6274325-B1 | USING A FAB'-BIOTIN MATERIAL AND AGGLUTINATABLE PARTICLES WHICH CARRY STREPTAVIDIN OR AVIDIN | BOEHRINGER MANNHEIM GMBH (DE) | 2001-08-14 | — | — | US | disclosed |